Integrated Wealth Concepts LLC lifted its position in shares of Doximity, Inc. (NASDAQ:DOCS - Free Report) by 89.5% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 13,380 shares of the company's stock after purchasing an additional 6,318 shares during the period. Integrated Wealth Concepts LLC's holdings in Doximity were worth $714,000 as of its most recent filing with the Securities and Exchange Commission.
Several other institutional investors and hedge funds also recently made changes to their positions in the company. Fuller & Thaler Asset Management Inc. grew its stake in shares of Doximity by 8.5% in the fourth quarter. Fuller & Thaler Asset Management Inc. now owns 1,579,708 shares of the company's stock worth $84,341,000 after purchasing an additional 124,216 shares during the last quarter. MGO One Seven LLC acquired a new stake in shares of Doximity in the fourth quarter valued at about $215,000. Massar Capital Management LP bought a new position in shares of Doximity during the fourth quarter worth about $1,791,000. Hsbc Holdings PLC acquired a new position in shares of Doximity in the fourth quarter worth approximately $891,000. Finally, Stifel Financial Corp boosted its holdings in Doximity by 4.5% in the fourth quarter. Stifel Financial Corp now owns 51,902 shares of the company's stock valued at $2,771,000 after acquiring an additional 2,228 shares during the last quarter. Institutional investors and hedge funds own 87.19% of the company's stock.
Insider Buying and Selling
In other Doximity news, Director Kira Scherer Wampler sold 2,000 shares of the business's stock in a transaction on Thursday, May 1st. The shares were sold at an average price of $56.93, for a total transaction of $113,860.00. Following the sale, the director now owns 16,618 shares of the company's stock, valued at $946,062.74. The trade was a 10.74 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, CFO Anna Bryson sold 45,000 shares of the firm's stock in a transaction on Thursday, May 1st. The stock was sold at an average price of $57.23, for a total value of $2,575,350.00. Following the completion of the transaction, the chief financial officer now directly owns 357,165 shares of the company's stock, valued at $20,440,552.95. The trade was a 11.19 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 37.40% of the stock is currently owned by corporate insiders.
Doximity Price Performance
Shares of DOCS stock traded up $0.93 on Wednesday, hitting $58.03. The stock had a trading volume of 264,857 shares, compared to its average volume of 1,999,023. Doximity, Inc. has a 12-month low of $22.96 and a 12-month high of $85.21. The stock has a market cap of $10.83 billion, a price-to-earnings ratio of 58.16, a price-to-earnings-growth ratio of 4.10 and a beta of 1.41. The business has a 50 day moving average of $58.58 and a 200 day moving average of $56.90.
Analysts Set New Price Targets
A number of brokerages have recently issued reports on DOCS. Wells Fargo & Company restated an "equal weight" rating on shares of Doximity in a research report on Friday, February 7th. Piper Sandler raised Doximity from a "neutral" rating to an "overweight" rating and boosted their price objective for the company from $31.00 to $78.00 in a research note on Friday, February 7th. Canaccord Genuity Group raised their target price on Doximity from $60.00 to $71.00 and gave the stock a "hold" rating in a research note on Friday, February 7th. Morgan Stanley dropped their price target on Doximity from $71.00 to $60.00 and set an "equal weight" rating on the stock in a research note on Thursday, April 24th. Finally, KeyCorp lowered their price objective on shares of Doximity from $83.00 to $70.00 and set an "overweight" rating for the company in a research note on Wednesday, April 16th. Eleven investment analysts have rated the stock with a hold rating, eight have given a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat, Doximity currently has a consensus rating of "Moderate Buy" and a consensus target price of $65.39.
Read Our Latest Report on DOCS
Doximity Company Profile
(
Free Report)
Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.
Recommended Stories

Before you consider Doximity, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Doximity wasn't on the list.
While Doximity currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.